F
Frontier Derm Partners | Mill Creek, WA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Apremilast
Rocatinlimab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.
Active, not recruiting
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo
The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 1...
Enrolling
Plaque Psoriasis
Drug: Apremilast
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems